ERSP urges compliance with testimonial guidelines
This article was originally published in The Tan Sheet
Executive Summary
The Electronic Retailing Self-Regulation Program lauds Nathans Natural for discontinuing claims that its ViLift Anti-Depressant Formula is "rated superior" and "clinically proven" to rid consumers of anxiety and depression. However, the watchdog group Oct. 1 chastised the supplement marketer for replacing the claims with equally inappropriate claims about the product's performance. ERSP says the marketer referenced the historical herbal efficacy of the product's primary ingredient, but did not demonstrate it can "cure" depression or anxiety. ERSP also recommended the New York-based firm discontinue testimonials that do not comply with the Federal Trade Commission's Guide on the Use of Endorsements and Testimonials in Advertising. Nathans Natural says it disagrees with ERSP's conclusions but will comply
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.